Business Wire (Free subscription) | 09/10/2008
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries,
Medical News Today (Free subscription) | 23/09/2008
U.S. spending on health care services is "under pressure" as Americans are "cutting back on health care," an area of the economy "once thought to be invulnerable to recession," the Wall Street Journal reports. According to IMS Health, the number of prescriptions filled decreased by 0.5% from a year earlier in the first quarter and by 1.97% from a year earlier in the second quarter.
Business Wire (Free subscription) | 18/09/2008
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries,
The Earth Times Online Newspaper (Free subscription) | 27/08/2008
NORWALK, Conn. - IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that David Carlucci, chairman and chief executive officer, will speak to investors and analysts attendi
Business Wire (Free subscription) | 27/08/2008
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries,
Furdlog (Free subscription) | 20/08/2008
We can hope it’ll be good enough for us: Data miners fight law that shields doctors (pdf) Companies like IMS Health Inc., based in Norwalk, Conn., have built an industry around gathering prescription data and selling the information to pharmaceutical companies for millions of dollars each year. Pfizer Inc., Merck & Co. Inc., and nearly every [...]
On Our Radar Today (Free subscription) | 20/08/2008
A number of states have begun to consider legislation that would restrict access to physician prescribing information for data mining companies as part of a "backlash against pharmaceutical marketing efforts," the AP/Arizona Republic reports. Data mining companies, such as IMS Health and Verispan , collect information on which medications physicians prescribe and the quantities in which they prescribe...
Red Orbit (Free subscription) | 13/08/2008
IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced significant enhancements to its global suite of patient-centered longitudinal disease and treatment insights.
Seeking Alpha (Free subscription) | 22/07/2008
IMS Health (RX) Q2 FY08 Earnings Call Complete Story »
Market Watch (Free subscription) | 21/07/2008
NEW YORK (MarketWatch) -- IMS Health said Monday that second-quarter earnings were $77.7 million, or 42 cents a share, compared to $73.4 million, or 36 cents, in the year-ago period. Revenue was $600.7 million, comapared to $537.5 million. "Led by 26% growth in our Consulting and Services business and accelerating results in the emerging markets, IMS delivered a very solid quarter," said CEO David...
Business Wire (Free subscription) | 21/07/2008
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries,
Seeking Alpha (Free subscription) | 18/07/2008
IMS Health (RX) is scheduled to report Q2 earnings Monday, July 21 before market open, with a conference call scheduled for 8 am ET. Guidance Analysts are expecting a profit of 40c on revenue of $590.27M. The consensus range for EPS is 39c to 42c, with a revenue range of $574.70M to $599.80M, according to First Call. On May 28 IMS Health gave FY08 EPS guidance of $170 to $1.76 vs. consensus of $1.73....
Pharmalot (Free subscription) | 16/07/2008
The number of prescriptions dispensed by US pharmacies is growing at its worst rate in at least a decade as consumers are squeezed by both a troubled economy and the growing burden of out-of-pocket health-care costs, The Wall Street Journal reports. Data from IMS Health and Wall Street analysts indicate that the rate of prescription growth [...]
Business Wire (Free subscription) | 15/07/2008
NORWALK, Conn.--(BUSINESS WIRE)--The Board of Directors of IMS Health (NYSE: RX) today declared a regular third-quarter 2008 dividend of $0.03 per share, payable on September 5, 2008 to
Business Wire (Free subscription) | 09/07/2008
NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries,
